Healthcare (Medicare)

in committee · United States · Senate Jan 29, 2026

S 3750: REAL Health Providers Act

The REAL Health Providers Act (S 3750) requires Medicare Advantage plans to maintain accurate, up-to-date provider directories for beneficiaries, starting in 2028. Plans must verify provider information at least every 90 days (or annually for hospitals), remove outdated listings within 5 business days, and indicate when information may be inaccurate. If a beneficiary is treated by a provider listed in the directory but not in the network, the plan must cover costs as if the provider were in-network. Annual accuracy reports will be submitted by plans and publicly posted by the government starting in 2029.

Topics ✓ HealthcareSupports HealthcareRequires Medicare Advantage plans to maintain accurate provider directories and cover costs for listed out-of-network providers, improving patient access and protecting beneficiary rights from surprise billing.95% confidence

Sub-Topics Medicare

Track

in committee · United States · House Feb 4, 2026

HR 2433: Reducing Medically Unnecessary Delays in Care Act of 2025

This bill requires Medicare plans (including Medicare Advantage and prescription drug plans) to base coverage decisions on medical necessity and evidence-based standards. It mandates that plans seek input from practicing physicians when creating or changing coverage rules, post all preauthorization requirements online in plain language, and publicly share statistics on approvals and denials. The bill also requires that adverse coverage decisions be made by licensed, board-certified physicians and prohibits denying coverage solely due to lack of evidence-based standards when none exist for a service. These changes aim to reduce unnecessary delays in care for Medicare beneficiaries by increasing transparency and clinical input in coverage decisions.

Topics ✓ HealthcareSupports HealthcareMandates evidence-based Medicare coverage decisions with physician input, increasing transparency and reducing care delays, improving patient access to necessary services.95% confidence

Sub-Topics Medicare Prescription Drugs

Track

in committee · United States · Senate Jul 31, 2025

S 2617: Reducing Drug Prices for Seniors Act.

This bill changes how Medicare Part D coinsurance is calculated for seniors. Starting in 2026, for drug costs above the deductible but below the out-of-pocket limit, coinsurance will be based on the drug's *net price* (the actual negotiated price after manufacturer discounts) instead of the list price. It directly affects Medicare Part D beneficiaries and prescription drug plans by requiring plans to use the net price when calculating these costs. The net price is defined as the discounted price reported in the Detailed DIR Report, excluding manufacturer discounts. This change aims to reduce out-of-pocket costs for seniors by aligning coinsurance with the lower price paid by the plan.

Topics ✓ HealthcareSupports HealthcareReduces seniors' out-of-pocket drug costs by basing coinsurance on net price instead of list price, improving affordability under Medicare Part D.95% confidence

Sub-Topics Medicare Prescription Drugs Tags Seniors

Track

in committee · United States · Senate Jul 31, 2025

S 2612: SAFE Act

Stopping Addiction and Falls for the Elderly Act or the SAFE Act This bill incorporates risk assessments and prevention services for falls into annual wellness visits and initial preventive physical exams under Medicare, as well as associated services provided by physical therapists and occupational therapists.

Topics ✓ HealthcareSupports HealthcareBill expands Medicare coverage to include fall risk assessments and prevention services during wellness visits, improving patient access to preventive care for elderly.95% confidence

Sub-Topics Medicare Substance Abuse

Track

in committee · United States · Senate Dec 15, 2025

S 3480: Seniors Deserve SMARTER Care Act of 2025

This bill prohibits the implementation of the WISeR model under Medicare, specifically blocking the Secretary of Health and Human Services from adopting the "Medicare Program; Implementation of Prior Authorization for Select Services for the Wasteful and Inappropriate Services Reduction (WISeR) Model" or any similar model. It directly affects Medicare beneficiaries and providers by preventing a new payment and service delivery approach that would require prior authorization for certain services. The key provision is a direct ban on the WISeR model's rollout, as outlined in the July 1, 2025, federal notice. This change would maintain current Medicare approval processes for affected services without creating new requirements. The bill does not establish new benefits or alter existing Medicare coverage rules.

Topics ✓ HealthcareSupports HealthcareBlocks WISeR model's prior authorization requirements, preventing restrictions on Medicare services and protecting beneficiary access to care.95% confidence

Sub-Topics Long-Term Care Medicare Tags Seniors

Track

in committee · United States · House Mar 10, 2025

HR 2013: Medicare Home Health Accessibility Act

This bill amends Medicare eligibility rules to clarify that beneficiaries needing occupational therapy *or* speech therapy qualify for home health services. It updates two sections of the Social Security Act (Parts A and B) to replace "need occupational therapy or speech therapy" with "need occupational, or speech therapy," ensuring both therapies are explicitly covered. The change directly affects Medicare beneficiaries requiring either therapy for home-based care, removing potential confusion about eligibility. The updated rules will take effect for services provided on or after January 1, 2026.

Topics ✓ HealthcareSupports HealthcareBill clarifies Medicare eligibility to explicitly cover both occupational and speech therapy, removing confusion and improving access to home health services for beneficiaries.95% confidence

Sub-Topics Long-Term Care Medicare

Track

in committee · United States · Senate May 12, 2025

S 1717: Ensuring Patient Access to Critical Breakthrough Products Act of 2025

S 1717, the Ensuring Patient Access to Critical Breakthrough Products Act of 2025, requires Medicare to cover FDA-designated "breakthrough" medical devices during a 4-year transitional period starting when the device is approved. This directly affects Medicare beneficiaries (Part A/B enrollees) and device manufacturers, ensuring coverage for these innovative products while FDA reviews their safety. The bill mandates that Medicare’s coverage decisions for these devices must be finalized within 9-12 months before the 4-year period ends, and allows coverage denial only if clinical data shows the device poses undue risk. It also allocates $10 million annually (2026-2031) to fund Medicare’s implementation of these coverage rules.

Topics ✓ HealthcareSupports HealthcareMandates Medicare coverage for FDA-designated breakthrough devices, expanding patient access to innovative medical products during transitional period.95% confidence

Sub-Topics Medicare Telehealth

Track

in committee · United States · House Jan 14, 2025

HR 307: ARC Act of 2025

HR 307, the ARC Act of 2025, aims to reduce avoidable amputations by expanding access to peripheral artery disease (PAD) screening and prevention. It requires Medicare and Medicaid to cover PAD screening tests (like ankle-brachial index tests) without cost-sharing for at-risk beneficiaries, including seniors, diabetics, and those with other vascular risk factors. The bill also establishes a federal education program to raise awareness about PAD and creates quality measures to incentivize hospitals to prioritize non-amputation treatments through early detection. These provisions directly affect millions of Americans, particularly minorities disproportionately impacted by PAD-related amputations, by making preventive care more accessible and integrated into routine care.

Topics ✓ HealthcareSupports HealthcareExpands Medicare/Medicaid coverage for PAD screening without cost-sharing for at-risk groups, directly advancing preventive healthcare access and reducing barriers for vulnerable populations.95% confidence

Sub-Topics Medicaid Medicare Primary Care

Track

in committee · United States · Senate Oct 21, 2025

S 3019: No Big Blockbuster Bailouts Act

S 3019, the "No Big Blockbuster Bailouts Act," amends Medicare's drug price negotiation program to change how orphan drugs (treatments for rare diseases) are handled. It raises the revenue threshold from $200 million to $400 million before orphan drugs become subject to price negotiations under Medicare. This directly affects pharmaceutical companies developing drugs solely for rare diseases, as they will face price negotiations only if their annual U.S. revenue exceeds $400 million. The change applies to initial price negotiations starting January 1, 2028.

Topics ✗ HealthcareOpposes HealthcareRaises orphan drug revenue threshold from $200M to $400M, delaying Medicare price negotiations and limiting government cost controls on rare disease treatments.85% confidence

Sub-Topics Medicare Prescription Drugs

Track

in committee · United States · Senate Sep 17, 2025

S 2830: WELL Seniors Act of 2025

The WELL Seniors Act of 2025 expands Medicare's annual wellness visit program to better address seniors' health and social needs. It requires screenings for fall risk and assessments of food security, housing, transportation, and social support, with providers receiving a 10% payment incentive for including at least two additional elements beyond standard care. The bill also allows these visits to be provided via telehealth and adds physical therapists, occupational therapists, and pharmacists as eligible providers starting in 2026. Additionally, it mandates a national education campaign and research study to improve uptake, particularly for low-income and rural seniors.

Topics ✓ HealthcareSupports HealthcareExpands Medicare wellness visits with social need screenings and provider incentives, improving senior healthcare access and comprehensive care services.95% confidence

Sub-Topics Long-Term Care Medicare Telehealth Tags Seniors

Track